Binding of Liposomes to Human Bladder Tumor Epithelial Cell Lines: Implications for an Intravesical Drug Delivery System for the Treatment of Bladder Cancer
1989; Mary Ann Liebert, Inc.; Volume: 5; Issue: 4 Linguagem: Inglês
10.1089/sct.1989.5.147
ISSN2332-4988
AutoresJOHN W. JOHNSON, Rajiv Nayar, Jerald J. Killion, Andrew C. von Eschenbach, Isaiah J. Fidler,
Tópico(s)Mass Spectrometry Techniques and Applications
ResumoSelective Cancer TherapeuticsVol. 5, No. 4 Binding of Liposomes to Human Bladder Tumor Epithelial Cell Lines: Implications for an Intravesical Drug Delivery System for the Treatment of Bladder CancerJOHN W. JOHNSON, RAJIV NAYAR, JERALD J. KILLION, ANDREW C. von ESCHENBACH, and ISAIAH J. FIDLERJOHN W. JOHNSON, RAJIV NAYAR, JERALD J. KILLION, ANDREW C. von ESCHENBACH, and ISAIAH J. FIDLERPublished Online:2 Apr 2009https://doi.org/10.1089/sct.1989.5.147AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byNano-Formulation Based Intravesical Drug Delivery Systems: An Overview of Versatile Approaches to Improve Urinary Bladder Diseases8 September 2022 | Pharmaceutics, Vol. 14, No. 9A review of recent developments on micro/nanostructured pharmaceutical systems for intravesical therapy of the bladder cancer12 April 2017 | Pharmaceutical Development and Technology, Vol. 23, No. 1Increased endocytosis of magnetic nanoparticles into cancerous urothelial cells versus normal urothelial cells18 August 2017 | Histochemistry and Cell Biology, Vol. 149, No. 1Intravesical liposome therapy for interstitial cystitis4 March 2017 | International Journal of Urology, Vol. 24, No. 4Innovative Intravesical Therapies6 June 2017A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatmentJournal of Controlled Release, Vol. 238Advances in intravesical therapy for urinary tract disorders19 October 2015 | Expert Opinion on Drug Delivery, Vol. 13, No. 1Review: Application of Nanoparticles in Urothelial Cancer of the Urinary Bladder11 August 2015 | Journal of Medical and Biological Engineering, Vol. 35, No. 4Intravesical Liposome and Antisense Treatment for Detrusor Overactivity and Interstitial Cystitis/Painful Bladder SyndromeISRN Pharmacology, Vol. 2014Applications of Nanotechnology in Bladder Cancer TherapyJournal of Healthcare Engineering, Vol. 3, No. 4An intravesical device for the sustained delivery of lidocaine to the bladderJournal of Controlled Release, Vol. 149, No. 2Strategies to improve drug delivery in bladder cancer therapy19 June 2009 | Expert Opinion on Drug Delivery, Vol. 6, No. 7Intravesical pharmacologic treatment for neurogenic detrusor overactivity1 March 2013New Frontiers in Intravesical Therapies and Drug DeliveryEuropean Urology, Vol. 50, No. 6Kinetic model of drug distribution in the urinary bladder wall following intravesical instillationInternational Journal of Pharmaceutics, Vol. 322, No. 1-2Efficacy of Paclitaxel Released From Bio-Adhesive Polymer Microspheres on Model Superficial Bladder CancerJournal of Urology, Vol. 171, No. 3Influence of chitosan and polycarbophil on permeation of a model hydrophilic drug into the urinary bladder wallInternational Journal of Pharmaceutics, Vol. 256, No. 1-2Internalization of microbubbles by tumor cellsin vivo andin vitroJournal of Neuro-Oncology, Vol. 26, No. 1Photodynamic therapy of human bladder carcinoma cells in vitro with pH-sensitive liposomes as carriers for 9-acetoxy-tetra-n-propylporphyceneUrological Research, Vol. 22, No. 1The Development of Liposomes Containing Interferon Alpha for the Intravesical Therapy of Human Superficial Bladder CancerJournal of Urology, Vol. 143, No. 6 Volume 5Issue 4Jan 1989 To cite this article:JOHN W. JOHNSON, RAJIV NAYAR, JERALD J. KILLION, ANDREW C. von ESCHENBACH, and ISAIAH J. FIDLER.Binding of Liposomes to Human Bladder Tumor Epithelial Cell Lines: Implications for an Intravesical Drug Delivery System for the Treatment of Bladder Cancer.Selective Cancer Therapeutics.Jan 1989.147-155.http://doi.org/10.1089/sct.1989.5.147Published in Volume: 5 Issue 4: April 2, 2009PDF download
Referência(s)